Perform Another (Advanced) Search

1.  Study Posting (4519) Trial #138180, Non-Small Cell Lung Cancer, Vaxjo, Sweden
...138180, Non-Small Cell Lung Cancer, Vaxjo, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

2.  Study Posting (4519) Trial #135188, Non-Small Cell Lung Cancer, Umea, Sweden
...135188, Non-Small Cell Lung Cancer, Umea, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

3.  Study Posting (4519) Trial #132470, Non-Small Cell Lung Cancer, Stockholm, Sweden
...132470, Non-Small Cell Lung Cancer, Stockholm, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

4.  Study Posting (4519) Trial #132489, Non-Small Cell Lung Cancer, Malmoe, Sweden
...132489, Non-Small Cell Lung Cancer, Malmoe, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

5.  Study Posting (4519) Trial #132516, Non-Small Cell Lung Cancer, Lund, Sweden
...132516, Non-Small Cell Lung Cancer, Lund, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

6.  Study Posting (4519) Trial #132655, Non-Small Cell Lung Cancer, Goeteborg, Sweden
...132655, Non-Small Cell Lung Cancer, Goeteborg, Sweden Trial Information MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash Status: Completed Protocol Number ...
...Division: Pharmaceutical Official Scientific Title: MATER An open label study to assess the effect of metronidazole actavis 1% topical cream in the prevention and treatment of Tarceva-associated rash in patients ...
View Page

7.  Study Posting (799) Trial #153246, Rosacea, Boston, MA
...study to investigate the efficacy of topical azelaic acid (AzA) 15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in ...
...study to investigate the efficacy of topical azelaic acid (AzA) 15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in ...
View Page

8. Clinical Trial Results by Drug Names
...by Drug Names Clinical Trial Result Information Title of Study: MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash. Fast Facts: Protocol number ...
View Page

9.  Newly Approved Drug Therapies (355) Flagyl ER, Searle,
...Information Flagyl ER, a new, once-daily, oral drug delivery system containing 750 mg of metronidazole, has been approved for marketing by the FDA. Flagyl ER is an extended release formulation of the anti-infective agent, metronidazole. It is the first and only once-a-day oral medication approved for the treatment ...
View Page

10.  Newly Approved Drug Therapies (396) Noritate, Dermik Laboratories,
...Noritate Company: Dermik Laboratories Approval Status: Approved January 1998 Treatment Area: Rosacea General Information Noritate (metronidazole cream) 1% has been approved as a topical rosacea therapy for the treatment of inflammatory ...
View Page

11.  Newly Approved Drug Therapies (207) Cipro (ciprofloxacin) I.V. and Cipro (ciprofloxacin HCI) tablets, Bayer,
...I.V. and Cipro (ciprofloxacin HCI) tablets has been approved for use in combination with metronidazole, for treatment of complicated intra-abdominal infections caused by E. coli, Pseudomonas aeruginosa, Proteus mirabilis ...
...Klebsiella pneumoniae, or Bacteroides fragilis. This study showed that conversion to oral therapy with ciprofloxacin/metronidazole appears as effective as continued intravenous therapy in patients able to tolerate oral feedings. Side ...
View Page

12.  Newly Approved Drug Therapies (504) MetroLotion, Galderma Laboratories,
...Side Effects MetroLotion Topical Lotion is contraindicated in individuals with a history of hypersensitivity to metronidazole or to other ingredients of the formulation. Also local allergic reaction, contact dermatitis, skin discomfort ...
...erythema and the following additional adverse experiences have been reported with the topical use of metronidazole: skin irritation, transient redness, metallic taste, tingling or numbness of extremities, and nausea. Mechanism of ...
View Page

13.  CenterWatch: New Medical Therapies in Disease Category (514), Vaginitis
...vaginosis. The drug was tested in over 400 female subjects as an adjunct to standard metronidazole therapy. Treatment with CTV-05 resulted in vaginal colonization by lactobacillus crispatus in 62% of ...
View Page

14.  CenterWatch: New Medical Therapies in Disease Category (317), Vaginal Infection
...vaginosis. The drug was tested in over 400 female subjects as an adjunct to standard metronidazole therapy. Treatment with CTV-05 resulted in vaginal colonization by lactobacillus crispatus in 62% of ...
View Page

15.  Newly Approved Drug Therapies (873) Tindamax, tinidazole, Presutti Laboratories,
...tinidazole dose was also assessed in 4 open label trials in men (one comparative to metronidazole and 3 single arm studies). Parasitological evaluation of the urine was performed both pre- and ...
...of these trials where the comparator was 2 to 3 days of various doses of metronidazole, reported cure rates for metronidazole were 76% (19/25) to 93% (14/15). Data comparing ...
View Page

16.  CenterWatch: Clinical Trials in Category (293) Rosacea
...study to investigate the efficacy of topical azelaic acid (AzA) 15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in ...
View Page

17.  Study Posting (4410) Trial #96081, Clostridium Difficile-Associated Diarrhea, Encinitas, CA
...in the last 24 hours) • Not be on a C. difficile-active antibiotic (vancomycin or metronidazole) for more than 24 hours • Able to read, understand English and follow simple instructions Qualified ...
View Page

18.  Newly Approved Drug Therapies (278) Cipro (ciprofloxacin HCl), Bayer,
...adults including lower respiratory infections, urinary tract infections, chronic bacterial prostatis, intra-abdominal infections (with metronidazole), bone and joint infections, and skin and skin structure infections. Jobson Medical Information • Privacy | • Glossary ...
View Page

19.  Study Posting (4410) Trial #111305, Clostridium Difficile-Associated Diarrhea, Encinitas, CA
...in the last 24 hrs) • Not be on a C. difficile-active antibiotic (vancomycin or metronidazole) for more than 24 hours • Able to read, understand English and follow simple instructions Qualified ...
View Page

20.  CenterWatch: New Medical Therapies in Disease Category (554), Clostridium Difficile-Associated Diarrhea
...blind, placebo-controlled study enrolled 200 subjects symptomatic with CDAD receiving standard of care antibiotics (metronidazole or vancomycin). The subjects received either intravenous placebo or intravenous administration of a combination of ...
...blind, placebo-controlled study enrolled 200 subjects symptomatic with CDAD receiving standard of care antibiotics (metronidazole or vancomycin). The subjects received either intravenous placebo or intravenous administration of a combination of ...
View Page